Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5dcd3235523586c8bc4ce40a5824a32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_689d532e7f712c780cb4cec200f16fef http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6b1be225a24db038a56dfa605ea1f86 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-64 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12 |
filingDate |
2009-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c7bde816b1e080eb56c8dee89cc14b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73d0227dbb5c219b57dc515b1b586240 |
publicationDate |
2010-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2010017587-A1 |
titleOfInvention |
Novel protease inhibitors |
abstract |
The invention relates to KLK protease inhibitors. In particular, the invention is directed to KLK4 protease inhibitors and their uses in the treatment of a cancer, such as prostate cancer. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3122758-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019049933-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2019049933-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11208467-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7191834-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012083385-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3680335-A4 |
priorityDate |
2008-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |